b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29133514</PMID>\n        <DateCompleted>\n            <Year>2019</Year>\n            <Month>09</Month>\n            <Day>12</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>06</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1549-490X</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>23</Volume>\n                    <Issue>3</Issue>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>03</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>The oncologist</Title>\n                <ISOAbbreviation>Oncologist</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>First Prospective Multicenter Italian Study on the Impact of the 21-Gene Recurrence Score in Adjuvant Clinical Decisions for Patients with ER Positive/HER2 Negative Breast Cancer.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>297-305</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1634/theoncologist.2017-0322</ELocationID>\n            <Abstract>\n                <AbstractText Label="BACKGROUND">The Breast DX Italy prospective study evaluated the impact of the 21-gene recurrence score (RS) result on adjuvant treatment decisions for patients with early breast cancer.</AbstractText>\n                <AbstractText Label="MATERIALS AND METHODS">Nine centers (two Hub and seven Spoke centers of the Veneto Oncology Network) participated. Consecutive patients with estrogen receptor positive, human epidermal growth receptor negative, T1-T3, N0-N1 early breast cancer were prospectively registered; only those meeting protocol-defined clinicopathological &quot;intermediate risk&quot; criteria were eligible for the RS test. Pre-RS and post-RS physicians\' treatment recommendations and treatment actually received were collected.</AbstractText>\n                <AbstractText Label="RESULTS">A total of <i>n</i>\xe2\x80\x89=\xe2\x80\x89124 N0 and <i>n</i>\xe2\x80\x89=\xe2\x80\x89126 N1 patients underwent the RS assay. The majority had Grade 2 tumors (71%); median age was 55 years, median tumor size was 16 mm, and median Ki67 expression was 20%. Patients enrolled at Hub centers presented higher-risk features. The distribution of RS results was &lt;18 (60.8%), 18-30 (32.4%), and &gt;30 (6.8%). The indication before RS was hormonal therapy (HT) alone in 52% of cases. An indication before RS of chemotherapy (CT)+HT was more frequent for patients with N1 versus N0 tumors (57% vs. 39%, <i>p</i>\xe2\x80\x89=\xe2\x80\x89.0035) and for patients enrolled at Hub versus Spoke centers (54% vs. 36%, <i>p</i>\xe2\x80\x89=\xe2\x80\x89.007).The overall rate of change in treatment decision was 16% (<i>n</i>\xe2\x80\x89=\xe2\x80\x8940), mostly from CT+HT to HT (<i>n</i>\xe2\x80\x89=\xe2\x80\x8930). According to nodal status, rate of change in treatment decision was 12% for the N0 cohort and 20% for the N1 cohort. The proportion of patients recommended to CT+HT was significantly reduced from before to after RS (48% to 40%, <i>p</i>\xe2\x80\x89&lt;\xe2\x80\x89.0016), especially in the N1 cohort (57% to 45%, <i>p</i>\xe2\x80\x89=\xe2\x80\x89.0027) and at Hub centers (54% to 44%, <i>p</i>\xe2\x80\x89=\xe2\x80\x89.001).</AbstractText>\n                <AbstractText Label="CONCLUSION">Despite frequent indication of HT before RS, the use of the RS assay further contributed to sparing CT, especially for patients with N1 tumors and at Hub centers.</AbstractText>\n                <AbstractText Label="IMPLICATIONS FOR PRACTICE">This study shows that, although a high proportion of patients were recommended to receive endocrine treatment alone before knowing the recurrence score (RS) assay, the RS test further contributed in sparing chemotherapy for some of these patients, especially in case of the N1 stage or for patients enrolled at referral centers. These data highlight the need for further work in collaboration with health authorities and companies in order to define strategies for the implementation of the use of RS testing in clinical practice in the Italian setting.</AbstractText>\n                <CopyrightInformation>\xc2\xa9 AlphaMed Press 2017.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Dieci</LastName>\n                    <ForeName>Maria Vittoria</ForeName>\n                    <Initials>MV</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology 2, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Guarneri</LastName>\n                    <ForeName>Valentina</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology 2, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Giarratano</LastName>\n                    <ForeName>Tommaso</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mion</LastName>\n                    <ForeName>Marta</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology, Ospedale Civile, Camposampiero, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tortora</LastName>\n                    <ForeName>Giampaolo</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>De Rossi</LastName>\n                    <ForeName>Costanza</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology Department, Angelo General Hospital, Mestre and SS Giovanni e Paolo General Hospital, Venezia, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gori</LastName>\n                    <ForeName>Stefania</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Oncology Unit, Ospedale Sacro Cuore-don Calabria, Negrar, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Oliani</LastName>\n                    <ForeName>Cristina</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Oncology Unit, AULSS8 Berica Distretto Ovest, Vicenza, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Merlini</LastName>\n                    <ForeName>Laura</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Medical Oncology, Ospedale Civile S Bortolo, Vicenza, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Pasini</LastName>\n                    <ForeName>Felice</ForeName>\n                    <Initials>F</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Oncology, Ospedale Civile, Rovigo, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bonciarelli</LastName>\n                    <ForeName>Giorgio</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology, Azienda Euganea 6, Padova Sud, Monselice, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Griguolo</LastName>\n                    <ForeName>Gaia</ForeName>\n                    <Initials>G</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Orvieto</LastName>\n                    <ForeName>Enrico</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Pathology, Azienda Ospedaliera di Padova, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Michieletto</LastName>\n                    <ForeName>Silvia</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Breast Surgery Unit, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Saibene</LastName>\n                    <ForeName>Tania</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Breast Surgery Unit, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Del Bianco</LastName>\n                    <ForeName>Paola</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>De Salvo</LastName>\n                    <ForeName>Gian Luca</ForeName>\n                    <Initials>GL</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Clinical Trials and Biostatistics Unit, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Conte</LastName>\n                    <ForeName>PierFranco</ForeName>\n                    <Initials>P</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Surgery, Oncology, and Gastroenterology, University of Padova, Padova, Italy pierfranco.conte@unipd.it.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Medical Oncology 2, Istituto Oncologico Veneto - IRCCS, Padova, Italy.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D016448">Multicenter Study</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>13</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Oncologist</MedlineTA>\n            <NlmUniqueID>9607837</NlmUniqueID>\n            <ISSNLinking>1083-7159</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D018931">Antineoplastic Agents, Hormonal</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D014408">Biomarkers, Tumor</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D011960">Receptors, Estrogen</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018931" MajorTopicYN="N">Antineoplastic Agents, Hormonal</DescriptorName>\n                <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017024" MajorTopicYN="N">Chemotherapy, Adjuvant</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000066491" MajorTopicYN="N">Clinical Decision-Making</DescriptorName>\n                <QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020869" MajorTopicYN="N">Gene Expression Profiling</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008207" MajorTopicYN="N">Lymphatic Metastasis</DescriptorName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009362" MajorTopicYN="N">Neoplasm Metastasis</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009364" MajorTopicYN="N">Neoplasm Recurrence, Local</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011960" MajorTopicYN="N">Receptors, Estrogen</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Adjuvant chemotherapy</Keyword>\n            <Keyword MajorTopicYN="Y">Early breast cancer</Keyword>\n            <Keyword MajorTopicYN="Y">Estrogen receptor positive</Keyword>\n            <Keyword MajorTopicYN="Y">Recurrence score</Keyword>\n            <Keyword MajorTopicYN="Y">Treatment change</Keyword>\n        </KeywordList>\n        <CoiStatement>Disclosures of potential conflicts of interest may be found at the end of this article.</CoiStatement>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>07</Month>\n                <Day>11</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>10</Month>\n                <Day>02</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>9</Month>\n                <Day>13</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29133514</ArticleId>\n            <ArticleId IdType="pii">theoncologist.2017-0322</ArticleId>\n            <ArticleId IdType="doi">10.1634/theoncologist.2017-0322</ArticleId>\n            <ArticleId IdType="pmc">PMC5905682</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>N Engl J Med. 2004 Dec 30;351(27):2817-26</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15591335</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2015 Sep;26 Suppl 5:v8-30</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26314782</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>NPJ Breast Cancer. 2016 Jun 08;2:16017</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28721379</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2013 Sep;24(9):2206-23</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23917950</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2006 Aug 10;24(23):3726-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16720680</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2005 May 14-20;365(9472):1687-717</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15894097</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2014 Jul 10;371(2):107-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24881463</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Apr 10;28(11):1829-34</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20212256</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>N Engl J Med. 2015 Nov 19;373(21):2005-14</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26412349</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CA Cancer J Clin. 2017 Jul 8;67(4):290-303</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28294295</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2013 Mar;24(3):618-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23136233</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2013 Mar 9;381(9869):805-16</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23219286</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2017 Aug 1;28(8):1700-1712</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28838210</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Breast Cancer Res Treat. 2013 Jul;140(1):83-92</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23801158</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2017 Apr;75:284-298</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28259011</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Surg Oncol. 2017 May;43(5):931-937</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28111076</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Ann Oncol. 2015 Aug;26(8):1533-46</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25939896</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2016 Jul 10;34(20):2341-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26926676</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2016 Apr 1;34(10):1134-50</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26858339</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Cancer. 2016 Oct;66:104-13</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27544930</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet Oncol. 2010 Jan;11(1):55-65</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20005174</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2016 Apr 1;34(10):1065-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">26598746</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Oncol. 2010 Apr 1;28(10):1671-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">20065191</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nat Rev Clin Oncol. 2015 May;12(5):296-301</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">25781576</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'